Answers are grounded in this paper and cite their sources.
Case analysis reports iatrogenic botulism after botulinum toxin injection at an unlicensed clinic, highlighting regulatory and public health issues.
Iatrogenic botulism is a rare side effect but serious complication may arise from botulinum neurotoxin (BoNT) administration. We report a case 21-year-old woman who developed bulbar symptoms following cosmetic BoNT injection at unlicensed beauty centre, and diagnosis was made based on history, physical examinations and exclusion of other neurological disorders. This case report emphasizing on proper BoNT administration, prompt and early recognition of complications and the need for regulatory body surveillance. Broader implications are also discussed, including public health concerns, diagnostic challenges, therapeutic considerations, and the importance of practitioner education.
No takes yet. Share an insight, caveat, or question.
Jamaluddin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: